TAILORx trial finds most women with early breast cancer do not benefit from chemotherapy

Findings from the TAILORx clinical trial show chemotherapy does not benefit most women with early breast cancer. The new data, released at the 2018 ASCO annual meeting, will help inform treatment decisions for many women with early-stage breast cancer.

https://ift.tt/2HfzhZZ